Comprehensive Clinical Guide: Median Arcuate Ligament Syndrome (MALS)

1. Introduction and Clinical Overview

Median Arcuate Ligament Syndrome (MALS), also historically referred to as Dunbar syndrome or celiac artery compression syndrome, is a rare and complex clinical entity characterized by the extrinsic compression of the celiac artery by the median arcuate ligament of the diaphragm. This anatomical impingement often leads to a triad of symptoms: chronic postprandial abdominal pain, weight loss, and, in some cases, the presence of an abdominal bruit.

While the exact prevalence of MALS remains elusive due to the high frequency of asymptomatic anatomical compression found in the general population, it represents a significant cause of unexplained chronic abdominal pain in clinical practice. The syndrome sits at the intersection of vascular surgery, gastroenterology, and pain management, requiring a multidisciplinary approach for definitive diagnosis and treatment.

2. Deep-Dive: Etiology and Pathophysiology

The Anatomical Mechanism

The median arcuate ligament is a fibrous arch that unites the diaphragmatic crura on either side of the aortic hiatus. In a normal anatomical configuration, this ligament passes superior to the origin of the celiac artery. In patients with MALS, the ligament inserts lower than normal on the diaphragm, causing it to cross directly over the celiac artery trunk.

Pathophysiological Theories

The pathophysiology of MALS is debated and generally categorized into two primary theories, often working in tandem:

1. Vascular/Ischemic Theory: The compression reduces blood flow to the foregut (stomach, liver, spleen, and proximal pancreas). During the postprandial state, when splanchnic blood flow demand increases, the fixed stenosis prevents adequate perfusion, leading to visceral ischemia and subsequent pain.
2. Neuropathic Theory: The celiac plexus, a dense network of nerves surrounding the celiac artery, is compressed alongside the vessel. Chronic irritation or inflammation of these nerve fibers is believed to be a major contributor to the neuropathic pain profile observed in many patients.

Anatomical Risk Factors

• Low-lying diaphragm: A congenital predisposition to a lower insertion point of the crura.
• Aortic position: Variations in the height of the celiac axis origin relative to the diaphragm.
• Body habitus: Patients with low BMI and minimal retroperitoneal fat are more prone to symptomatic compression, as the lack of adipose cushioning exacerbates the impingement.

3. Clinical Staging and Presentation

Standard Presentation

MALS typically presents in patients between the ages of 30 and 50, with a notable female predominance (often cited as 3:1 to 4:1).

Diagnostic Staging (Clinical Grading)

While there is no formal universal staging system, clinicians often grade MALS based on the severity of the stenosis and the impact on the patient’s quality of life:

• Grade 1 (Asymptomatic): Anatomical compression present on imaging; no clinical symptoms.
• Grade 2 (Mild/Intermittent): Anatomical compression + intermittent postprandial pain; manageable with diet.
• Grade 3 (Severe/Chronic): Anatomical compression + debilitating pain, significant weight loss, and potential secondary celiac plexus involvement.

4. Differential Diagnosis

Because the symptoms of MALS are non-specific, it is frequently a diagnosis of exclusion. Clinicians must rule out:

• Gastrointestinal: Chronic pancreatitis, peptic ulcer disease, cholecystitis, gastroparesis, and inflammatory bowel disease.
• Vascular: Chronic mesenteric ischemia (atherosclerotic), vasculitis, or dissection.
• Neurological: Referred pain from spine pathology or chronic neuropathic pain syndromes.
• Gynecological: Endometriosis or ovarian pathology (in female patients).

5. Key Diagnostic Tests

A robust diagnostic workup requires multimodal imaging to confirm both the anatomical compression and the hemodynamic impact.

Imaging Modalities

1. Duplex Ultrasound (DUS): Often the first-line screening tool. It assesses flow velocity in the celiac artery. Peak systolic velocities (PSV) >200 cm/s are highly suggestive of significant stenosis.
2. CT Angiography (CTA): The gold standard for anatomical visualization. It shows the "hooked" appearance of the celiac artery and the degree of ligamentous impingement.
3. Magnetic Resonance Angiography (MRA): Useful for patients where iodinated contrast (CTA) is contraindicated.
4. Lateral Angiography: Provides dynamic, real-time visualization of the celiac artery during respiration, confirming the compression is dynamic.

The Celiac Plexus Block (Diagnostic/Prognostic)

A temporary celiac plexus nerve block is often used to differentiate between ischemic pain and neuropathic pain. If the block results in significant, albeit temporary, relief of symptoms, it strongly supports the diagnosis of MALS and suggests that the patient may benefit from surgical decompression and neurolysis.

6. Risks, Side Effects, and Contraindications

Surgical Intervention

The primary treatment is laparoscopic or robotic-assisted celiac artery release, which involves the division of the median arcuate ligament and extensive celiac ganglionectomy (neurolysis).

• Surgical Risks:
  • Vascular injury (celiac artery rupture or pseudoaneurysm).
  • Injury to adjacent structures (aorta, pancreas).
  • Post-operative gastroparesis (due to autonomic nerve disruption).
  • Recurrence of symptoms due to fibrous tissue regrowth.
• Contraindications:
  • Severe, untreated atherosclerosis (where flow is dependent on collateral circulation).
  • High surgical risk patients with significant cardiopulmonary comorbidities.

7. Long-Term Prognosis

The prognosis for patients undergoing surgical decompression is generally favorable, with success rates ranging from 70% to 85%. However, long-term outcomes are highly dependent on patient selection. Patients with "classic" symptoms (postprandial pain + weight loss) and positive diagnostic imaging have the highest probability of surgical success. Patients who have had symptoms for a very long duration may have established central sensitization, where pain persists even after the physical compression is relieved.

8. Frequently Asked Questions (FAQ)

1. Is MALS a hereditary condition?

MALS is generally considered an anatomical variation rather than a strictly hereditary disease, though the anatomical predisposition (the height of the diaphragmatic crura) can occasionally run in families.

2. Can MALS be treated without surgery?

Non-surgical management, such as nutritional counseling, physical therapy for posture, and celiac plexus blocks, can provide temporary relief, but surgery remains the only definitive cure for the anatomical compression.

3. What is the role of the celiac plexus in MALS?

The celiac plexus is a bundle of nerves surrounding the artery. In MALS, this plexus is compressed, leading to chronic neuropathic pain. Neurolysis (removal of these nerve fibers) is a critical part of the surgical procedure.

4. Why is MALS so difficult to diagnose?

MALS is often missed because the anatomical compression exists in many healthy, asymptomatic individuals. Therefore, imaging alone is insufficient; the symptoms must correlate strictly with the findings.

5. Does weight loss worsen MALS?

Yes. Weight loss reduces the amount of retroperitoneal fat that normally cushions the celiac artery, which can increase the severity of the compression and worsen symptoms.

6. Are there specific diets for MALS patients?

While there is no "MALS diet," patients often find relief by eating smaller, more frequent, low-fat meals to reduce the workload on the digestive system and minimize postprandial ischemic pain.

7. Can MALS lead to long-term organ damage?

If left untreated, chronic ischemia can lead to persistent weight loss, malnutrition, and, in rare instances, the development of collateral vessels (like the pancreaticoduodenal arcades) that can become aneurysmal.

8. What is the difference between MALS and Chronic Mesenteric Ischemia (CMI)?

CMI is typically caused by atherosclerotic plaque buildup inside the arteries, whereas MALS is caused by an external force (the ligament) pressing on the artery.

9. What is the success rate of surgery?

Studies report that 70–85% of patients experience significant symptom improvement after surgical release of the ligament and neurolysis.

10. How long is the recovery from MALS surgery?

Most patients require 2–4 weeks of recovery time after laparoscopic surgery, with a gradual return to normal diet and activity levels as the digestive system adjusts.

9. Conclusion

Median Arcuate Ligament Syndrome remains a diagnosis of clinical nuance. While imaging provides the anatomical roadmap, the diagnosis relies heavily on the expert synthesis of the patient’s symptom profile. As diagnostic technology advances and our understanding of the celiac plexus improves, the management of MALS continues to evolve toward more minimally invasive, highly targeted surgical interventions that offer patients a path to resolution and improved quality of life.